Celerion Funding Round

4/23/2026

Venture Equity

Unknown

Undisclosed

The company intends to use the funds to support its continued growth and innovation, expand its clinical and bioanalytical capabilities and advance its work to help pharmaceutical and biotechnology partners.

Private & Independent

Biopharmaceutical

621 Rose Street
Lincoln, NE 68502
USA

Our 50+ years of experience, innovative strategies, global capabilities, and expertise in early phase research make us faster than our competitors. That means you get key data sooner, enabling you to make earlier go/no-go decisions about your drug's development. It's all in the name: Celerion is derived from the Latin celeritas (meaning swiftness and speed), which reflects our founding principle--that fast, reliable research is vital to a product's success. Our vision is to be the premier provider of early stage drug development solutions to you, achieved through experienced leadership, the passion of our employees and a commitment to excellence.